Skip to main content

Table 1 Eligibility criteria for patient risk groups that were screened for C. auris

From: Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018

Group

Description

Notes

Group 1 (n = 92)

recent hospitalization outside of Canada

time periods defining recent overseas hospitalization (0.5, 1, or 2 years) varied as per each hospital policy

Group 2 (n = 117)

recent travel to the Indian subcontinent without hospitalization

time periods defining recent travel (1 or 2 years) varied as per each hospital policy

Group 3 (n = 104)

CPO colonized or infected inpatients or outpatients and consenting participants in a different prospective CPO cohort study

 

Group 4 (n = 282)

units that are associated with intensive antifungal use

patients identified by hospital census on a single day

Group 5 (n = 0)

hospital contacts of a C. auris index case

screening as per each hospital policy